• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNF207通过对TAB1进行翻译后修饰加剧病理性心脏肥大。

RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1.

作者信息

Yuan Lin, Bu Shichen, Du Meng, Wang Yilong, Ju Chenhui, Huang Dandan, Xu Wenjing, Tan Xin, Liang Minglu, Deng Shan, Yang Liu, Huang Kai

机构信息

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan 430022, Hubei, China.

Clinic Center of Human Genomic Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China.

出版信息

Cardiovasc Res. 2023 Mar 17;119(1):183-194. doi: 10.1093/cvr/cvac039.

DOI:10.1093/cvr/cvac039
PMID:35352799
Abstract

AIMS

The heart undergoes pathological remodelling, featured by the hypertrophic growth of cardiomyocytes and increased cardiac fibrosis, under biomechanical stress such as haemodynamic overload. Ring Finger Protein 207 (RNF207) is an E3 ubiquitin ligase that is predominantly expressed in the heart, but its function remains elusive. In this study, we aimed to explore the role of RNF207 in the development of pathological cardiac hypertrophy and dysfunction.

METHODS AND RESULTS

Transverse aortic constriction (TAC) surgery was performed on mice to induce cardiac hypertrophy. Cardiac function and remodelling were evaluated by echocardiography, histological assessment, and molecular analyses. Our data indicated that RNF207 overexpression (OE) exacerbated cardiac hypertrophy, fibrosis, and systolic dysfunction. In contrast, TAC-induced cardiac remodelling was profoundly blunted in RNF207 knockdown (KD) hearts. In line with the in vivo findings, RNF207 OE augmented, whereas RNF207 KD alleviated, phenylephrine-induced cardiomyocyte hypertrophy in vitro. Mechanistically, we demonstrated that RNF207 elicited detrimental effects by promoting K63-linked ubiquitination of TAK1-binding protein 1 (TAB1), which triggered the autophosphorylation of transforming growth factor-β activated kinase 1 (TAK1) and the activation of downstream p38 and c-Jun N-terminal kinase (JNK)1/2 signalling pathways. In the TAB1-KD cardiomyocytes, RNF207-OE-induced cell hypertrophy was significantly attenuated, indicating that RNF207-induced hypertrophy is, at least in part, TAB1-dependent.

CONCLUSIONS

This study demonstrates that RNF207 exacerbates pressure overload-induced cardiac hypertrophy and dysfunction via post-translational modification of TAB1.

摘要

目的

在诸如血流动力学过载等生物力学应激下,心脏会经历病理性重塑,其特征为心肌细胞肥大性生长和心脏纤维化增加。环指蛋白207(RNF207)是一种E3泛素连接酶,主要在心脏中表达,但其功能仍不清楚。在本研究中,我们旨在探讨RNF207在病理性心脏肥大和功能障碍发展中的作用。

方法与结果

对小鼠进行横向主动脉缩窄(TAC)手术以诱导心脏肥大。通过超声心动图、组织学评估和分子分析来评估心脏功能和重塑。我们的数据表明,RNF207过表达(OE)加剧了心脏肥大、纤维化和收缩功能障碍。相比之下,在RNF207基因敲低(KD)的心脏中,TAC诱导的心脏重塑明显减弱。与体内研究结果一致,RNF207过表达增强了苯肾上腺素诱导的体外心肌细胞肥大,而RNF207基因敲低则减轻了这种肥大。机制上,我们证明RNF207通过促进TAK1结合蛋白1(TAB1)的K63连接的泛素化发挥有害作用,这触发了转化生长因子-β激活激酶1(TAK1)的自磷酸化以及下游p38和c-Jun氨基末端激酶(JNK)1/2信号通路的激活。在TAB1基因敲低的心肌细胞中,RNF207过表达诱导的细胞肥大明显减弱,表明RNF207诱导的肥大至少部分依赖于TAB1。

结论

本研究表明,RNF207通过对TAB1的翻译后修饰加剧压力超负荷诱导的心脏肥大和功能障碍。

相似文献

1
RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1.RNF207通过对TAB1进行翻译后修饰加剧病理性心脏肥大。
Cardiovasc Res. 2023 Mar 17;119(1):183-194. doi: 10.1093/cvr/cvac039.
2
Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.泛素特异性蛋白酶 19 通过抑制 TAK1 依赖性途径减弱病理性心肌肥厚。
J Cell Mol Med. 2020 Sep;24(18):10946-10957. doi: 10.1111/jcmm.15724. Epub 2020 Aug 14.
3
Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.三重基序蛋白8通过增强转化生长因子β激活激酶1依赖性信号通路促进病理性心肌肥大。
Hypertension. 2017 Feb;69(2):249-258. doi: 10.1161/HYPERTENSIONAHA.116.07741. Epub 2016 Dec 12.
4
Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.靶向 E3 泛素连接酶 WWP1 通过抑制 K27 连接泛素化来破坏 DVL2,从而防止心肌肥厚。
Circulation. 2021 Aug 31;144(9):694-711. doi: 10.1161/CIRCULATIONAHA.121.054827. Epub 2021 Jun 18.
5
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.泛素 E3 连接酶 TRAF6 通过 TAK1 依赖性信号转导加重病理性心肌肥厚。
Nat Commun. 2016 Jun 1;7:11267. doi: 10.1038/ncomms11267.
6
Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.肌特异性环指蛋白 1 通过下调钙调磷酸酶 A 负调控病理性心肌肥厚。
Circ Heart Fail. 2014 May;7(3):479-90. doi: 10.1161/CIRCHEARTFAILURE.113.000713. Epub 2014 Feb 13.
7
C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice.C1q-肿瘤坏死因子相关蛋白-3 加剧小鼠心肌肥厚。
Cardiovasc Res. 2019 May 1;115(6):1067-1077. doi: 10.1093/cvr/cvy279.
8
DEF6(differentially exprehomolog) exacerbates pathological cardiac hypertrophy via RAC1.DEF6(差异表达同源物)通过 RAC1 加剧病理性心肌肥厚。
Cell Death Dis. 2023 Jul 31;14(7):483. doi: 10.1038/s41419-023-05948-0.
9
SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1-Dependent Manner.SWAP70 过表达以 TAK1 依赖的方式保护病理性心肌肥厚。
J Am Heart Assoc. 2023 Apr 4;12(7):e028628. doi: 10.1161/JAHA.122.028628. Epub 2023 Mar 28.
10
RNF13 protects against pathological cardiac hypertrophy through p62-NRF2 pathway.环指蛋白 13 (RNF13)通过 p62-NRF2 通路来保护心脏免受病理性心肌肥大。
Free Radic Biol Med. 2023 Nov 20;209(Pt 2):252-264. doi: 10.1016/j.freeradbiomed.2023.10.395. Epub 2023 Oct 16.

引用本文的文献

1
QRICH1 regulates ATF6 transcription to affect pathological cardiac hypertrophy progression.QRICH1调节ATF6转录以影响病理性心肌肥厚进展。
Mol Med. 2025 May 13;31(1):183. doi: 10.1186/s10020-025-01241-2.
2
Mapping the transcriptional and epigenetic landscape of organotypic endothelial diversity in the developing and adult mouse.绘制发育中和成年小鼠器官型内皮多样性的转录和表观遗传图谱。
Nat Cardiovasc Res. 2025 Apr;4(4):473-495. doi: 10.1038/s44161-025-00618-0. Epub 2025 Mar 17.
3
Association of the TTN, PDK4, and RNF207 mutations with dilated cardiomyopathy in Dobermanns from the United Kingdom.
英国杜宾犬中TTN、PDK4和RNF207突变与扩张型心肌病的关联
PLoS One. 2025 Mar 13;20(3):e0319932. doi: 10.1371/journal.pone.0319932. eCollection 2025.
4
Emerging Role of Targeting Deubiquitinating Enzymes to Inhibit Pathological Cardiac Hypertrophy.靶向去泛素化酶抑制病理性心肌肥大的新作用
J Am Heart Assoc. 2025 Mar 18;14(6):e039732. doi: 10.1161/JAHA.124.039732. Epub 2025 Mar 5.
5
Deubiquitinase Ubiquitin-Specific Protease 29 Ameliorates Pathological Cardiac Hypertrophy through Inhibiting Transforming Growth Factor β-Activated Kinase 1.去泛素化酶泛素特异性蛋白酶29通过抑制转化生长因子β激活激酶1改善病理性心脏肥大。
J Am Heart Assoc. 2025 Mar 18;14(6):e034962. doi: 10.1161/JAHA.124.034962. Epub 2025 Mar 5.
6
Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy.全基因组关联分析为扩张型心肌病的分子病因学提供了见解。
Nat Genet. 2024 Dec;56(12):2646-2658. doi: 10.1038/s41588-024-01952-y. Epub 2024 Nov 21.
7
MicroRNA-27a-5p Downregulates Expression of Proinflammatory Cytokines in Lipopolysaccharide-Stimulated Human Dental Pulp Cells via the NF-κB Signaling Pathway.miR-27a-5p 通过 NF-κB 信号通路下调脂多糖刺激的人牙髓细胞中促炎细胞因子的表达。
Int J Mol Sci. 2024 Sep 7;25(17):9694. doi: 10.3390/ijms25179694.
8
TMEM100 acts as a TAK1 receptor that prevents pathological cardiac hypertrophy progression.TMEM100 作为 TAK1 受体发挥作用,可防止病理性心肌肥厚进展。
Cell Commun Signal. 2024 Sep 11;22(1):438. doi: 10.1186/s12964-024-01816-2.
9
attenuates radiation-induced cardiac hypertrophy and apoptosis by degrading in cardiomyocytes.通过降解心肌细胞中的……来减轻辐射诱导的心脏肥大和细胞凋亡。 (原文中“by degrading”后缺少具体内容)
Acta Biochim Biophys Sin (Shanghai). 2024 Aug 29;56(12):1733-1747. doi: 10.3724/abbs.2024130.
10
Crosstalk of ubiquitin system and non-coding RNA in fibrosis.泛素系统与非编码RNA在纤维化中的相互作用
Int J Biol Sci. 2024 Jul 8;20(10):3802-3822. doi: 10.7150/ijbs.93644. eCollection 2024.